| Individual Articles - Jul/Aug 2001 - Sterile Product Compounding |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Quality Assurance for Sterile Products
Kastango Eric S, Douglass Kate
|
Jul/Aug 2001
Pg. 246-253
|
Sterile Compounding with Barrier-Isolation Technology
Rahe Hank
|
Jul/Aug 2001
Pg. 254-258
|
Bacterial Endotoxins and Pyrogens
Jones Marty
|
Jul/Aug 2001
Pg. 259-263
|
Evolution of the United States Pharmacopeia Chapter <1206>: "Sterile Preparations - Pharmacy Practices"
Okeke Claudia C, Barletta Frank, Newton David W, Allen Loyd V Jr
|
Jul/Aug 2001
Pg. 265-267
|
Antineoplastic Agents
Ashworth Lisa D
|
Jul/Aug 2001
Pg. 268-271
|
Compounding Issues and Accreditation Agencies
Petroff Barb
|
Jul/Aug 2001
Pg. 273-274
|
Book Reviews
Reed-Kane Dana
|
Jul/Aug 2001
Pg. 275-276
|
Sterile Compounding: Excerpts from the Reviews of Current Published Literature
MacCara Mary E
|
Jul/Aug 2001
Pg. 278-279
|
Evaluating Transdermal Medication Forms for Veterinary Patients, Part 3: Methimazole
Davidson Gigi S
|
Jul/Aug 2001
Pg. 282-283
|
Analytical Testing Facilities and Products
Hudson Sonora
|
Jul/Aug 2001
Pg. 284-286
|
Formulations for Success, Part 2
Vail Jane
|
Jul/Aug 2001
Pg. 287-289
|
Wish You Were Here: The Stabler-Leadbeater Apothecary Museum
Worthen Dennis B
|
Jul/Aug 2001
Pg. 290-292
|
Basics of Compounding: Suspensions
Allen Loyd V Jr
|
Jul/Aug 2001
Pg. 294-297
|
Suspension Structured Vehicle, USP
Allen Loyd V Jr
|
Jul/Aug 2001
Pg. 296
|
Sugar-Free Suspension Structured Vehicle, USP
Allen Loyd V Jr
|
Jul/Aug 2001
Pg. 296
|
Spironolactone Oral Suspension 2-mg/mL
Allen Loyd V Jr
|
Jul/Aug 2001
Pg. 297
|
Progesterone Oral Suspension 40-mg/mL
Allen Loyd V Jr
|
Jul/Aug 2001
Pg. 297
|
Progesterone Enema 200-mg/mL
Allen Loyd V Jr
|
Jul/Aug 2001
Pg. 297
|
Xanthan Gum Oral Suspension Vehicle 0.3%
Allen Loyd V Jr
|
Jul/Aug 2001
Pg. 297
|
Wound Care Mixture
Allen Loyd V Jr
|
Jul/Aug 2001
Pg. 297
|
Cefazolin Ophthalmic Solution, USP 0.35- mg/mL
Allen Loyd V Jr
|
Jul/Aug 2001
Pg. 300
|
Cyclopentolate HCl 0.5%, Phenylephrine HCl 2.5%, and Tropicamide 0.5% Ophthalmic Solution
Allen Loyd V Jr
|
Jul/Aug 2001
Pg. 301
|
Fibrin Glue
Allen Loyd V Jr
|
Jul/Aug 2001
Pg. 302
|
Hyaluronidase Injection
Allen Loyd V Jr
|
Jul/Aug 2001
Pg. 303
|
Hypertonic Sodium Chloride 20% Sclerotherapy Injections
Allen Loyd V Jr
|
Jul/Aug 2001
Pg. 304
|
Metronidazole and Neomycin Sulfate Irrigation Solution
Allen Loyd V Jr
|
Jul/Aug 2001
Pg. 305
|
Pediatric Preoperative Cocktail Injection
Allen Loyd V Jr
|
Jul/Aug 2001
Pg. 306
|
Phenylephrine 0.25% Ophthalmic Solution, Preservative Free
Allen Loyd V Jr
|
Jul/Aug 2001
Pg. 307
|
Sclerotherapy Injections of Phenol for Pain Management
Allen Loyd V Jr
|
Jul/Aug 2001
Pg. 308
|
Tissue Plasminogen Activator (TPA) 25-mcg/100-mcL Ophthalmic Solution
Allen Loyd V Jr
|
Jul/Aug 2001
Pg. 309
|
Wetting and/or Solubilizing Agents, Featured Excipient:
Allen Loyd V Jr
|
Jul/Aug 2001
Pg. 310-312
|
Maintenance of the Cleanroom
Allen Loyd V Jr
|
Jul/Aug 2001
Pg. 313
|
Incompatibilities of Lansoprazole Injection with Other Drugs During Simulated Y-Site Coadministration
Trissel Lawrence A, Saenz Christopher, Williams Kimberly Y, Ingram Delshalonda S
|
Jul/Aug 2001
Pg. 314-319
|
A New High-Performance Liquid Chromatographic Method for Fludarabine and Fludarabine Phosphate Compounded in Liposomes
Abang Anthony M, Abbas S Ali, Pham Trinh, Lambros Maria Polikandritou
|
Jul/Aug 2001
Pg. 320-322
|
Compatibility and Stability of Potassium Chloride and Magnesium Sulfate in 0.9% Sodium Chloride Injection and 5% Dextrose Injection Solutions
Quay Irene, Tan Edward
|
Jul/Aug 2001
Pg. 323-324
|
Calculations
Prince Shelly J
|
Jul/Aug 2001
Pg. 325
|
PostScription: pH Values of Nafcillin Sodium in 0.9% Sodium Chloride Injection After the Addition of Sodium Bicarbonate Injection To Prevent Phlebitis - A Letter to the Editor
Gupta Vishnu D
|
Jul/Aug 2001
Pg. 328
|
